The fight to get a liver transplant for Norman Smith took another big step today with a Reason TV expose, “Transplant Denied,” featuring Smith and Steph Sherer, Executive Director of Americans for Safe Access (ASA), the group that’s throwing its weight behind the struggling medical marijuana patient.
Smith, 63, was diagnosed with liver cancer in 2009 and was put on a transplant waiting list at the world-renowned Cedars-Sinai Medical Center. However a year ago, after becoming eligible for a transplant, Smith was removed from the list for testing positive for medical marijuana use. It didn’t seem to matter that Smith’s oncologist at Cedars was the physician who had recommended its use.
This moving piece by Reason TV accurately conveys the life of a man hanging in the balance between policies based on moral judgment and the therapeutic benefits of medical marijuana. At his wit’s end, Smith tells Reason TV:
It’s only my life that I’m fighting for. What do I have to hide? I have nothing to hide.
Smith called his chances a “long shot,” but still wanted to “effect a change:”
It’s probably too late for me, but I hope it makes it easier for the next guy.
Unfortunately, there are plenty of other medical marijuana patients in California and other states who are suffering the same fate as Smith. With the authority for such decisions left to Cedars and transplant centers like it, the push for policy change must be directed locally. As such, ASA Chief Counsel Joe Elford sent a letter to Cedars, urging it to immediately re-list Smith and change it policy with regard to medical marijuana. So far, Cedars has refused to budge.
Stay tuned here at Voices from the Frontlines for next steps in the transplant case of Norman Smith and the outdated policies of Cedars-Sinai. In the meantime, view this additional video footage of Smith and his plight.
This entry was posted
on Wednesday, February 29th, 2012 at 1:28 pm and is filed under Americans for Safe Access (ASA), California, Federal, Medical Cannabis, Rescheduling.
You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.